EYLEA HD 8 mg/.07mL
aflibercept · INJECTION, SOLUTION · Regeneron Pharmaceuticals, Inc
No Recall History
Plain English
EYLEA HD is a injection, solution containing aflibercept at 8 mg/.07mL, taken intravitreal. Manufactured by Regeneron Pharmaceuticals, Inc.
Key Facts
- Brand Name
- EYLEA HD
- Generic Name
- aflibercept
- NDC Code (Product)
61755-051- Manufacturer
- Regeneron Pharmaceuticals, Inc
- Strength
- 8 mg/.07mL
- Dosage Form
- INJECTION, SOLUTION
- Route
- INTRAVITREAL
- Marketing Status
- Application #
- BLA761355
- Drug Class
- Vascular Endothelial Growth Factor Inhibitor [EPC]
- Marketing Start
- 08/18/2023
Recall History
No Recall HistoryFrequently Asked Questions
What is EYLEA HD used for?
EYLEA HD contains aflibercept. It is a injection, solution taken intravitreal. Consult your doctor for specific uses.
Is EYLEA HD a controlled substance?
EYLEA HD is not classified as a controlled substance by the DEA.
What is the generic name for EYLEA HD?
The generic name for EYLEA HD is aflibercept. There are 4 other brand versions of aflibercept.
What is the NDC code for EYLEA HD 8 mg/.07mL?
The NDC (National Drug Code) for EYLEA HD 8 mg/.07mL is 61755-051, listed by Regeneron Pharmaceuticals, Inc.